Amanote Research

Amanote Research

    RegisterSign In

Ibandronate in the Treatment of Pediatric Osteoporosis

Bone Abstracts
doi 10.1530/boneabs.3.pp409
Full Text
Open PDF
Abstract

Available in full text

Date

May 1, 2014

Authors
Stepan KutilekIvana Plasilova
Publisher

Bioscientifica


Related search

Clinical Efficacy and Safety of Monthly Oral Ibandronate 100 Mg Versus Monthly Intravenous Ibandronate 1 Mg in Japanese Patients With Primary Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2015English

Dose-Response Study of Ibandronate in the Treatment of Cancer-Associated Hypercalcaemia

British Journal of Cancer
Cancer ResearchOncology
1997English

Treatment of Osteoporosis.

BMJ
1967English

The Diagnosis and Treatment of Osteoporosis

Yeungnam University Journal of Medicine
2008English

National Trends in Osteoporosis Visits and Osteoporosis Treatment, 1988-2003

Archives of Internal Medicine
2004English

The Role of Hormone Therapy in the Treatment of Osteoporosis

Journal of Endocrinology, Metabolism and Diabetes of South Africa
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

The Implementation of Personalized Treatment for Osteoporosis

Japanese Journal of Geriatrics
GerontologyGeriatrics
2008English

Treatment Options for Osteoporosis

Mayo Clinic Proceedings
Medicine
1995English

Denosumab – A New Medication in the Treatment of Postmenopausal Osteoporosis

Przeglad Menopauzalny
GynecologyEndocrinologyMetabolismObstetricsDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy